AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

MLP SAĞLIK HİZMETLERİ A.Ş.

Transaction in Own Shares May 25, 2022

8921_rns_2022-05-25_0a4079d9-07ab-4006-8d4f-f2ed223cc49f.html

Transaction in Own Shares

Open in Viewer

Opens in native device viewer

Summary Info Notification Regarding Initiation of Share Buy-Back
Update Notification Flag No
Correction Notification Flag No
Postponed Notification Flag No
Company Performs the Buy-Back MLP SAĞLIK HİZMETLERİ A.Ş.
Company Subject to Buy-Back MLP SAĞLIK HİZMETLERİ A.Ş.
Type Of Buy-Back Other
The Purpose of Buy-Back To support healthy price formation and to offer shareholders an attractive long-term investment opportunity
Board Decision Date 25.05.2022
Number Of Shares To Be Acquired 20.803.720

Additional Explanations

At the Board of Directors' meeting held by our Company on May 25, 2022, the following proposal was approved:

In order to support healthy price formation of MPARK shares in the equity market, to contribute to the formation of stable and appropriate share prices, to protect its shareholders and to offer them a more attractive long-term investment opportunity;

1) A share buy-back program for a period of one year shall be initiated pursuant to the Capital Markets Board's Communiqué on Share Buy-Back No. II-22.1 and the related announcements dated July 21, 2016 and July 25, 2016,

2) The maximum number of shares, which may be subject to the buy-back, shall be determined as TL 20,803,720.00- nominal (20,803,720.00- shares at a nominal value of TL 1 each), corresponding to 10% of the Company's issued capital,

3) The share buy-back shall be added to the agenda of the first following general assembly meeting, and shall be presented to the information and approval of the shareholders at the general assembly.

This statement has been translated into English for informational purposes. In case of a discrepancy between the Turkish and the English versions of this disclosure statement, the Turkish version shall prevail.

Talk to a Data Expert

Have a question? We'll get back to you promptly.